Germany Archives

allecra forbion delos antibiotic resistance

News and Trends 16 Jun 2016

Novel Antibiotic for Resistant Bacteria gets a €22M Push from Key Investors

Allecra Therapeutics has raised €22M in its Series B round from some key investors. The money will back the Phase II trials for a new broad-spectrum antibiotic for resistant bacteria. The development of antibiotic resistance in bacteria has been one of the key concerns of healthcare authorities for quite some time. The World Health Organisation estimates […]

June 16, 2016 - 3 minutesmins - By Denise Neves Gameiro

News and Trends 16 Jun 2016

This German Diagnostic company was sold for €50M to the World leading Molecular Diagnostic company

Sividon was a spin-off from Siemens, founded in July 2011 – and it was just sold to the American Myriad Genetics ($2.2Bn market cap) for €50M, even though the company raised only €5M over its lifetime. A clear success story that I discussed with Karlheinz Schmelig, partner of Sividon’s Lead investor Creathor Venture. Sividon worked in […]

June 16, 2016 - 2 minutesmins - By Philip Hemme

asco biotech morphosys cancer chicago 2016 researh pharma

News and Trends 9 Jun 2016

How was it inside the ‘World Most Important Cancer Meeting’ of the Year?

Every year by the end of May/beginning of June, up to 30,000 of healthcare professionals head to Chicago to discuss the most recent advancements in Cancer treatments. Here, the MorphoSys team, which included Claudia Gutjahr-Löser and Jochen Orlowski, give you a sneak-insiders look into one of the most essential Cancer conferences of the year… You can also […]

June 9, 2016 - 4 minutesmins - By Dani Bancroft

News and Trends 9 Jun 2016

German Biotech launches Phase II in a hot Target for Inflammation

InflaRx has treated the first patient in a new Phase II trial, which is studying the potential of its anti-complement antibody in avoiding immunological complications after complex cardiac surgery – a big unmet need. It is competing with world most expensive drug Soliris from Alexion (US). Based in Jena (Germany), InflaRx specializes in developing new […]

June 9, 2016 - 3 minutesmins - By Denise Neves Gameiro

global bioenergies l oreal loreal cristal union isobutene cosmetic biofuel biotech

News and Trends 9 Jun 2016

Biotech, France and L’Oréal Team up for World First Biofuel Plant using Beets

The Investissements d’Avenir programme (a French government initiative) is providing €9M to both Global Bioenergies and IBN-One, as part of an project involving Cristal Union (the agro-business for Beet production) and L’Oréal (the cosmetics Giant). Together, they will develop the first commercial plant producing bio-sourced isobutene worldwide. Broken down into €5.7M for Global Bioenergies; €3.3M for IBN-One, the […]

June 9, 2016 - 3 minutesmins - By Dani Bancroft

News and Trends 7 Jun 2016

New Massive €250M Investment Fund Closed for European Biotech

Life Sciences Partners (LSP) has closed its new life sciences fund, ‘LSP5’. The fund surpassed its €152M target and reached the ‘hard cap’ of €250M, making it one of the largest life sciences funds in the EU. LSP is one of the oldest and most successful Biotech investors in Europe. It claims over 25% return […]

June 7, 2016 - 2 minutesmins - By Dani Bancroft

cevec virus gene therapy paragon manufacture

News and Trends 7 Jun 2016

German Biotech partners up in the US for scalable viral vector production in Gene Therapy

Cevec is joining forces with US-based Paragon. The objective is to make Cevec’s scalable CAP expression technology the industry standard for glycoproteins and viral vectors in gene therapies. Based in Cologne (Germany), Cevec tackles with its human cell-based expression systems (CAP-GT and CAP-Go) two big challenges in Biotech manufacturing – industrial scale production of viral vectors […]

June 7, 2016 - 4 minutesmins - By Denise Neves Gameiro

biontech mrna vaccine cancer immunotherapy nature

News and Trends 2 Jun 2016

First All-Cancer mRNA Vaccine that Works Published in Nature

Update (05/07/2017): BioNTech has published new results in Nature revealing a strong immune response in all 13 patients treated with its personalized mRNA cancer vaccine, strengthening its potential to become a universal cancer vaccine. Originally published on 02/06/2016 BioNTech and its academic partners have published in the well-known publication Nature, describing the first clinically applicable and systemic […]

June 2, 2016 - 3 minutesmins - By Denise Neves Gameiro

crispr therapeutics gene editing labiotech refresh philip hemme biotech roger novak

News and Trends 1 Jun 2016

CRISPR Thx’ Founder: “We have over $250M in the bank”

So begins our series of videos documenting our biotech conference premier – Labiotech Refresh. Here Philip spoke with Rodger Novak, the CEO and founder of CRISPR Therapeutics, which is leading the biotech front on Gene Editing in Europe. Having the CEO of CRISPR Therapeutics come and speak at our first event was really exciting for […]

June 1, 2016 - 2 minutesmins - By Dani Bancroft

News and Trends 30 May 2016

Besides Techno, Berlin is also the place to be for Life Science Industries

On the 25th of May, the largest network event for life sciences and healthcare industries in the German capital region once again came to life for the 14th time, for Bionnale 2016 . As we too belong to this city, we are pleased to summarise the highlights of what happened there… This free event, which belongs to the Life Science’s […]

May 30, 2016 - 3 minutesmins - By Jerome Topsent

qiagen therawis diagnostics chemotherapy tnbc

News and Trends 26 May 2016

Qiagen partners up for Novel Diagnostic against Breast Cancer

Qiagen is partnering up with Therawis to develop a diagnostic test to predict how effective an aggressive chemotherapy will be in patients with high risk breast cancer. A giant in molecular diagnostics, Qiagen is now working in a new diagnostic test that could help guide the treatment of breast cancer. Now, Qiagen has partnered with […]

May 26, 2016 - 2 minutesmins - By Denise Neves Gameiro

international green week monsanto gmo bayer farmer protest acquisition offer biotech

News and Trends 23 May 2016

Bayer offers Big Buy out for the infamous Monsanto. Shareholders are not pleased…

Yes, everyone is talking about how Germany’s Pharma giant Bayer has made a $62 billion offer for the infamous chemicals conglomerate Monsanto. And not many like it. Bayer’s products mostly consist of human and veterinary pharmaceuticals, consumer healthcare products, agricultural chemicals, biotechnological products, and high value polymers. Monsanto on the other hand is notorious for its agricultural chemicals, GMOs […]

May 23, 2016 - 3 minutesmins - By Dani Bancroft

Resources

Categories

The twelve hottest biotech companies in the Boston area

Biotech bankruptcies: what to expect in 2024 following a record year?

Approaches

Therapeutic areas

RNA editing set to take off: could it outperform gene editing?

Future of cancer treatment: what will therapy look like in 2034?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The twelve hottest biotech companies in the Boston area

Biotech bankruptcies: what to expect in 2024 following a record year?

RNA editing set to take off: could it outperform gene editing?

Future of cancer treatment: what will therapy look like in 2034?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Germany

Novel Antibiotic for Resistant Bacteria gets a €22M Push from Key Investors

This German Diagnostic company was sold for €50M to the World leading Molecular Diagnostic company

How was it inside the ‘World Most Important Cancer Meeting’ of the Year?

German Biotech launches Phase II in a hot Target for Inflammation

Biotech, France and L’Oréal Team up for World First Biofuel Plant using Beets

New Massive €250M Investment Fund Closed for European Biotech

German Biotech partners up in the US for scalable viral vector production in Gene Therapy

First All-Cancer mRNA Vaccine that Works Published in Nature

CRISPR Thx’ Founder: “We have over $250M in the bank”

Besides Techno, Berlin is also the place to be for Life Science Industries

Qiagen partners up for Novel Diagnostic against Breast Cancer

Bayer offers Big Buy out for the infamous Monsanto. Shareholders are not pleased…

Subscribe to our newsletter to get the latest biotech news!